GE Aerospace doubling investments in U.S. factories with commercial and military jet-engine deliveries set to grow.

Ryan Specialty boasts accelerating growth and rising relative strength. Ryan Specialty stock is nearing a buy point.

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments ...

Physiological metrics captured via wearable devices may help identify and predict flares in inflammatory bowel disease, ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

A team led by researchers at the University of Toronto has discovered that a compound present in ginger selectively binds to ...

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection ...

Mental health comorbidities are more prevalent among transgender and gender nonconforming adults with IBD than the general and IBD US populations.

Spyre Therapeutics' innovative combination therapy approach targets multiple inflammatory pathways. Learn why SYRE stock is a Buy.

Environmental factors like diet and early antibiotic use have an impact on the gut microbiome and can contribute to ...

There is no way of telling when the stock market will turn around. It’s found in the Stock Lists tab along the top of Investors.com. The list holds industry group leaders that meet high standards for ...